title: Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.
abstract: For time-to-event data with finitely many competing risks, the proportional hazards model has been a popular tool for relating the cause-specific outcomes to covariates (Prentice and others, 1978. The analysis of failure time in the presence of competing risks. Biometrics 34, 541-554). Inspired by previous research in HIV vaccine efficacy trials, the cause of failure is replaced by a continuous mark observed only in subjects who fail. This article studies an extension of this approach to allow a multivariate continuum of competing risks, to better account for the fact that the candidate HIV vaccines tested in efficacy trials have contained multiple HIV sequences, with a purpose to elicit multiple types of immune response that recognize and block different types of HIV viruses. We develop inference for the proportional hazards model in which the regression parameters depend parametrically on the marks, to avoid the curse of dimensionality, and the baseline hazard depends nonparametrically on both time and marks. Goodness-of-fit tests are constructed based on generalized weighted martingale residuals. The finite-sample performance of the proposed methods is examined through extensive simulations. The methods are applied to a vaccine efficacy trial to examine whether and how certain antigens represented inside the vaccine are relevant for protection or anti-protection against the exposing HIVs.
authors: Department of Mathematics and Statistics, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.
authors: Yanqing
authors: Y
authors: Sun
authors: Mei
authors: M
authors: Li
authors: Peter B
authors: PB
authors: Gilbert
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology / Q000494:pharmacology*; D015415:Biomarkers / Q000032:analysis; D003198:Computer Simulation; D006678:HIV / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D018448:Models, Immunological; D016016:Proportional Hazards Models
chemical_list: D016915:AIDS Vaccines; D015415:Biomarkers